ArticleFrontiers in plant science2026
Comparative transcriptomic and rhizosphere microbiome profiling and cross-omics association analysis of wild and cultivated
Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: Transcriptomic and rhizosphere microbiome analyses were conducted in sampled wild and cultivated populations, followed by an exploratory cross-omics association analysis. Results: Transcriptome comparisons identified 10,416, 8,782, and 5,441 differentially expressed unigenes in roots, rhizomes, and leaves, respectively. Functional enrichment analyses showed differences in plant hormone signal transduction, MAPK signaling, plant-pathogen interaction, phenylpropanoid biosynthesis, and terpenoid biosynthesis pathways. Several terpenoid biosynthesis-related genes, including AACT, HMGS, HMGR, DXS, and TPS, had higher transcript levels in wild plants. Rhizosphere microbiome analyses showed differences in bacterial and fungal community composition among the sampled groups. Exploratory cross-omics analysis identified candidate associations between several microbial taxa and terpenoid biosynthesis-related genes. Discussion: These taxonomic assignments do not establish the functional roles of the detected microorganisms. Because terpenoid and saponin concentrations were not measured, the transcriptomic differences do not demonstrate greater metabolite accumulation or improved medicinal quality. Moreover, because the populations were sampled from different sites and the microbiome data lacked independent biological replication within each sampling group, the observed patterns do not establish effects of cultivation status or habitat, nor do they demonstrate causal plant-microbe interactions. The results provide hypotheses for future controlled studies of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.